HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial

Overview of attention for article published in Journal of Translational Medicine, April 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog

twitter: 1 X user
patent: 2 patents

Citations

dimensions_citation: 169 Dimensions

Readers on

mendeley: 179 Mendeley

Summary News Blogs X Patents Dimensions citations

So far, Altmetric has seen 1 X post from an account with 4,945 followers.

https://t.co/RCw36vAEOx "Patients with HPV16-positive...gynecological carcinoma (n = 20) were subcutaneously vaccinated with an HPV16-SLP vaccine...in Montanide" "No regression of tumors was observed among the 12 evaluable patients. Nineteen patients died

04 Sep 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.